Hoboken, NJ—Nearly anyone who has experienced the miserable sore throat, stuffy nose and congestion from a cold wants the symptoms to subside as quickly as possible. Now, new research from Otorrinolaringología suggests a branded extract from the French maritime pine bark (Pycnogenol, distributed by Horphag Research, with U.S. headquarters here) may help.
Sabinsa Corporation wrapped up its 2013 Sabinsa on Wheels series at the beginning of October, with a Weehawken, NJ event. This day-long educational event for its East Coast customers featured several speakers from the Sabinsa team, who spoke about the company and the science behind its proprietary dietary supplement ingredients.
Eagan, MN—Serious athletes who partake in long vigorous exercise (like marathoners) often experience impaired immune function after strenuous physical activity. Researchers now believe that a branded baker’s yeast beta-glucan (BG, Wellmune WGP from Biothera, based here) may help.
Cancer patients undergoing certain types of radiation treatment are prone to developing radiation-induced heart disease, especially when the heart is in the radiation area. A group led by researchers from the University of Arkansas for Medical Sciences recently examined whether taking both vitamin E a-tocopherol (as Tocomin SupraBio, from Carotech, with U.S. headquarters in Edison, NJ) and a drug called pentoxifylline (PTX) could help.
Ankeny, IA—Last winter (November 2012–March 2013), Swanson Health Products employees took part in the Swanson Wellness Awareness Program (SWAP) in which 120 people agreed to take EpiCor (from Embria Health Sciences, based here) to support their immune system. Of those, 72 completed a survey about their experience, and the results have just become available.
Oslo, Norway—A discrepancy over patents is continuing in the krill market segment. On October 2, Aker BioMarine asked the U.S. Trademarks and Patents Office (USTPO) to consider some additional evidence regarding the legitimacy of patent (U.S. Pat. No 8,278,351, i.e., the “’351 Patent”) assigned to Neptune Technologies & Bioressources Inc. of Laval, Quebec, Canada.